Show simple item record

dc.contributor.authorHuzmeli, Can
dc.contributor.authorSeker, Ayse
dc.contributor.authorCandan, Ferhan
dc.contributor.authorBagci, Gokhan
dc.contributor.authorAkkaya, Lale
dc.contributor.authorBakici, Mustafa Zahir
dc.contributor.authorKayatas, Mansur
dc.date.accessioned2019-07-27T12:10:23Z
dc.date.accessioned2019-07-28T09:39:34Z
dc.date.available2019-07-27T12:10:23Z
dc.date.available2019-07-28T09:39:34Z
dc.date.issued2018
dc.identifier.issn1300-7718
dc.identifier.urihttps://dx.doi.org/10.5262/tndt.2018.1001.08
dc.identifier.urihttps://hdl.handle.net/20.500.12418/6549
dc.descriptionWOS: 000425163400008en_US
dc.description.abstractOBJECTIVE: Occult hepatitis B (OHB) virus infection is defined as the presence of hepatitis B virus (HBV) DNA in the liver tissue or serum of subjects seronegative for hepatitis B surface antigen. OHB leads to the potential risk of transmission in dialysis service. Routine HBV vaccine in dialysis patients is recommended. However, HBV vaccine response rates are lower than the community. The aim of this study was to determine the prevalence of OHB in hepatitis B vaccinated dialysis patients. MATERIAL and METHODS: This study was performed at the Nephrology Department, Faculty of Medicine, Cumhuriyet University, between 1st January -31st December 2014. Sera from 200 dialysis patients with negative HbsAg were investigated for HBV DNA using the polymerase chain reaction (PCR). RESULTS: The mean age of the patients was 59.57 +/- 14.89 (18-91) years; 179 of them were on hemodialysis and 21 were on peritoneal dialysis. Of the patients included in the study, anti-HBs positivity was present in 135 (67.5%) and anti-HBs negativity in 65 (32.5%). The OHB prevalence was 1.5% (n=3). CONCLUSION: In our study, the OHB prevalence was 1.5%. We assume that HBV infection would be reduced further by routinely applying HBV PCR tests for all patients who start dialysis and by taking precautions against transmission.en_US
dc.description.sponsorshipCumhuriyet Universityen_US
dc.description.sponsorshipThe study was carried out with Cumhuriyet University Scientific Research Projects support.en_US
dc.language.isoengen_US
dc.publisherTURK NEFROLOJI DIYALIZ TRANSPLANTASYON DERGISIen_US
dc.relation.isversionof10.5262/tndt.2018.1001.08en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOccult hepatitis Ben_US
dc.subjectDialysisen_US
dc.subjectHepatitis B vaccineen_US
dc.titleOccult Hepatitis B Prevalence in Hepatitis B Vaccinated Dialysis Patientsen_US
dc.typearticleen_US
dc.relation.journalTURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNALen_US
dc.contributor.department[Huzmeli, Can -- Seker, Ayse -- Candan, Ferhan -- Akkaya, Lale -- Kayatas, Mansur] Cumhuriyet Univ, Fac Med, Dept Nephrol, Sivas, Turkey -- [Bagci, Gokhan] Cumhuriyet Univ, Fac Med, Dept Med Genet, Sivas, Turkey -- [Bakici, Mustafa Zahir] Cumhuriyet Univ, Fac Med, Dept Microbiol, Sivas, Turkeyen_US
dc.identifier.volume27en_US
dc.identifier.issue1en_US
dc.identifier.endpage62en_US
dc.identifier.startpage57en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record